Hariri Lida P, Mino-Kenudson Mari, Lanuti Michael, Miller Alyssa J, Mark Eugene J, Suter Melissa J
1 Division of Pulmonary and Critical Care Medicine, Department of Medicine.
Ann Am Thorac Soc. 2015 Feb;12(2):193-201. doi: 10.1513/AnnalsATS.201408-370OC.
Lung carcinoma diagnosis on tissue biopsy can be challenging because of insufficient tumor and lack of architectural information. Optical coherence tomography (OCT) is a high-resolution imaging modality that visualizes tissue microarchitecture in volumes orders of magnitude larger than biopsy. It has been proposed that OCT could potentially replace tissue biopsy.
We aim to determine whether OCT could replace histology in diagnosing lung carcinomas. We develop and validate OCT interpretation criteria for common primary lung carcinomas: adenocarcinoma, squamous cell carcinoma (SCC), and poorly differentiated carcinoma.
A total of 82 ex vivo tumor samples were included in a blinded assessment with 3 independent readers. Readers were trained on the OCT criteria, and applied these criteria to diagnose adenocarcinoma, SCC, or poorly differentiated carcinoma in an OCT validation dataset. After a 7-month period, the readers repeated the training and validation dataset interpretation. An independent pathologist reviewed corresponding histology.
The average accuracy achieved by the readers was 82.6% (range, 73.7-94.7%). The sensitivity and specificity for adenocarcinoma were 80.3% (65.7-91.4%) and 88.6% (80.5-97.6%), respectively. The sensitivity and specificity for SCC were 83.3% (70.0-100.0%) and 87.0% (75.0-96.5%), respectively. The sensitivity and specificity for poorly differentiated carcinoma were 85.7% (81.0-95.2%) and 97.6% (92.9-100.0%), respectively.
Although these results are encouraging, they indicate that OCT cannot replace histology in the diagnosis of lung carcinomas. However, OCT has potential to aid in diagnosing lung carcinomas as a complement to tissue biopsy, particularly when insufficient tissue is available for pathology assessment.
由于肿瘤组织不足以及缺乏组织结构信息,通过组织活检诊断肺癌可能具有挑战性。光学相干断层扫描(OCT)是一种高分辨率成像方式,能够在比活检大几个数量级的体积内可视化组织微结构。有人提出OCT有可能取代组织活检。
我们旨在确定OCT在诊断肺癌方面是否可以取代组织学检查。我们制定并验证了常见原发性肺癌(腺癌、鳞状细胞癌(SCC)和低分化癌)的OCT解读标准。
共有82个离体肿瘤样本纳入由3名独立阅片者进行的盲法评估。阅片者接受了OCT标准培训,并将这些标准应用于OCT验证数据集中诊断腺癌、SCC或低分化癌。7个月后,阅片者重复培训和验证数据集解读。一名独立病理学家复查了相应的组织学检查结果。
阅片者的平均准确率为82.6%(范围为73.7%-94.7%)。腺癌的敏感性和特异性分别为80.3%(65.7%-91.4%)和88.6%(80.5%-97.6%)。SCC的敏感性和特异性分别为83.3%(70.0%-100.0%)和87.0%(75.0%-96.5%)。低分化癌的敏感性和特异性分别为85.7%(81.0%-95.2%)和97.6%(92.9%-100.0%)。
尽管这些结果令人鼓舞,但表明OCT在肺癌诊断中不能取代组织学检查。然而,OCT有潜力作为组织活检的补充辅助诊断肺癌,特别是在没有足够组织进行病理评估时。